Found: 3
Select item for more details and to access through your institution.
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM‐3 antibody, in combination with decitabine or azacitidine in high‐ or very high‐risk myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E32, doi. 10.1002/ajh.27161
- By:
- Publication type:
- Article
Testing the efficacy of real-time fMRI neurofeedback for training people who smoke daily to upregulate neural responses to nondrug rewards.
- Published in:
- Cognitive, Affective & Behavioral Neuroscience, 2023, v. 23, n. 2, p. 440, doi. 10.3758/s13415-023-01070-y
- By:
- Publication type:
- Article
The association between perinatal hypoxia exposure and externalizing symptoms and children's decision making in conditions of uncertainty is moderated by DRD2 genotype.
- Published in:
- Developmental Psychobiology, 2019, v. 61, n. 1, p. 56, doi. 10.1002/dev.21785
- By:
- Publication type:
- Article